GSK Bio
NEWS
The brands Stada is picking up include venous treatment Venoruton, Coldrex for colds, Cetebe vitamin C supplements, Mebucaine for sore threats and Tavegyl for allergies, among others.
Immatics is eligible for more than $550 million in various commercial milestone payments for each product as well as additional royalties.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Vectura Group plc announces a key appointment to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space.
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
Pharma and biotech companies strengthen their leadership teams and boards with this weeks appointments.
One day after GlaxoSmithKline began to outline some of the broad strokes of splitting the company into two separate entities, more details are coming into place – particularly staffing concerns over the integration of the company’s vaccine business into its pharma operations.
One entity will focus on pharmaceuticals and drug development, while the other will be aimed at consumer healthcare.
The space will offer 1.6 million square feet of collaborative lab, office and lifestyle space.
JOBS
IN THE PRESS